The breast lesion localization device market was valued at USD 379.0 million in 2025, is projected to reach USD 623.0 million by 2035 and is forecast to register a 5.1% CAGR between 2025 and 2035. In 2025, breast biopsy holds 62.4% of application sales and wire localization represents 34.5% within the technique segment.